Anterior Uveitis (Iritis)

1. Comprehensive Executive Overview

Anterior uveitis, clinically synonymous with iritis, is a potentially sight-threatening intraocular inflammatory disorder. It represents the most common form of uveitis, accounting for approximately 60% to 90% of all uveitis cases in ophthalmic clinics.

Under the International Classification of Diseases, Tenth Revision, this condition is cataloged under ICD-10: H20.0 (Acute and subacute iridocyclitis).

Anatomical Classification

The uvea is the middle vascular tunic of the eye, anatomically divided into three distinct regions:
1. Anterior Uvea: Consisting of the iris (the colored contractile diaphragm) and the ciliary body (specifically the anterior portion or pars plicata).
2. Intermediate Uvea: Comprising the pars plana and vitreous humor.
3. Posterior Uvea: Comprising the choroid and retina.

              [THE UVEAL TRACT]
                     |
   +-----------------+-----------------+
   |                 |                 |

[Anterior Uvea] [Intermediate Uvea] [Posterior Uvea]
- Iris - Pars Plana - Choroid
- Ciliary Body - Vitreous - Retina
(Iritis/Cyclitis) (Pars Planitis) (Choroiditis)

Anterior uveitis primarily involves inflammation localized to the iris (iritis) or both the iris and the anterior ciliary body (iridocyclitis). When inflammation occurs in this anterior segment, inflammatory cells and proteins spill directly into the anterior chamber—the fluid-filled space between the cornea and the iris.

Because the iris and ciliary body are highly vascularized and immunologically active, they are highly sensitive to systemic autoimmune dysregulation, infectious pathogens, and local trauma. If left undiagnosed or inadequately managed, anterior uveitis can lead to irreversible ocular morbidity, including secondary glaucoma, cystoid macular edema (CME), band keratopathy, and inflammatory cataracts. Prompt diagnosis by an ophthalmologist (طب وجراحة العيون) is critical to preserving visual acuity.

2. Detailed Pathophysiology, Etiology, and Risk Factors

Pathophysiology: The Blood-Aqueous Barrier Breakdown

The fundamental pathophysiology of anterior uveitis centers on the disruption of the blood-aqueous barrier (BAB). Under physiological conditions, the BAB is maintained by tight junctions (zonulae occludentes) between:
* The non-pigmented ciliary epithelium of the ciliary body.
* The endothelial cells of the iris blood vessels.

This barrier strictly limits the passage of large proteins and cellular elements from the systemic circulation into the aqueous humor, maintaining optical clarity.

During an inflammatory episode, chemical mediators—including tumor necrosis factor-alpha (TNF-$\alpha$), interleukins (IL-1, IL-6, IL-8), and prostaglandins—are released. These cytokines induce vasodilation, increase vascular permeability, and upregulate adhesion molecules on the vascular endothelium.

Consequently, white blood cells (leukocytes) and plasma proteins extravasate into the anterior chamber.
* The suspended proteins scatter light under slit-lamp examination, a physical phenomenon known as the Tyndall effect (clinically graded as flare).
* The circulating leukocytes are visualized as floating particles (clinically graded as cells).

Systemic/Local Trigger
↓
Cytokine Release (TNF-α, IL-6, Prostaglandins)
↓
Disruption of Tight Junctions in Blood-Aqueous Barrier (BAB)
↓
Vasodilation & Hyperpermeability of Iris/Ciliary Vessels
↓
Extravasation of Proteins (Flare) & White Blood Cells (Cells) into Anterior Chamber

Etiology

Anterior uveitis is highly heterogeneous, classified broadly into non-infectious, infectious, and masquerade syndromes.

                       [ETIOLOGY]
                           |
     +---------------------+---------------------+
     |                                           |

[Non-Infectious] [Infectious]
| |
- HLA-B27 Associated - Viral (HSV, VZV, CMV)
- Systemic Autoimmune (Sarcoidosis, JIA) - Bacterial (Syphilis, TB)
- Idiopathic (up to 50%) - Parasitic (Toxoplasmosis)

1. Non-Infectious / Autoimmune (HLA-B27 Associated)

The HLA-B27 (Human Leukocyte Antigen B27) allele is a major histocompatibility complex (MHC) class I molecule strongly linked to anterior uveitis. Approximately 50% of patients presenting with acute anterior uveitis (AAU) test positive for the HLA-B27 marker. This genetic profile is associated with a group of autoimmune disorders known as seronegative spondyloarthropathies:
* Ankylosing Spondylitis (AS): Characterized by sacroiliitis and spinal stiffness.
* Reactive Arthritis (formerly Reiter’s Syndrome): Defined by the triad of urethritis, conjunctivitis/uveitis, and arthritis.
* Inflammatory Bowel Disease (IBD): Crohn's disease and Ulcerative Colitis.
* Psoriatic Arthritis: Inflammatory arthritis associated with psoriasis.

Other non-infectious systemic causes include Sarcoidosis (characterized by non-caseating granulomas), Juvenile Idiopathic Arthritis (JIA) (a major cause of chronic, asymptomatic, but highly destructive uveitis in children), and Tubulointerstitial Nephritis and Uveitis (TINU) syndrome.

2. Infectious Etiologies

Infectious pathogens can directly invade uveal tissue or trigger an immune reaction:
* Viral: Herpes Simplex Virus (HSV), Varicella Zoster Virus (VZV), and Cytomegalovirus (CMV). These typically present with unilateral inflammation, elevated intraocular pressure, and sectorial iris atrophy.
* Bacterial: Treponema pallidum (Syphilis - known as the great masquerader) and Mycobacterium tuberculosis (Tuberculosis).
* Parasitic: Toxoplasmosis (typically posterior, but can present with spillover anterior uveitis).

3. Idiopathic

In nearly 30% to 50% of anterior uveitis cases, no underlying systemic disease or infectious etiology can be identified despite an exhaustive medical workup.

Risk Factors

The risk of developing anterior uveitis is significantly elevated in individuals with:
* Genetic Predisposition: Carrying the HLA-B27 gene.
* Age and Sex: Typically peaks in young to middle-aged adults (20–50 years), though JIA-associated uveitis occurs in pediatric populations.
* Active Smoking: Clinical studies demonstrate that smoking increases the risk of developing uveitis and is associated with more frequent disease recurrences.

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of anterior uveitis varies depending on whether the disease is acute (sudden onset, lasting less than 3 months), chronic (persistent inflammation with rapid relapse within 3 months of stopping therapy), or recurrent (repeated episodes separated by inactive periods of at least 3 months).

Patient Symptoms

• Ocular Pain: Typically described as a deep, boring, or aching pain localized in and around the orbit. The pain is exacerbated by accommodation (focusing on near objects) due to the contraction of the inflamed ciliary muscle.
• Photophobia (Extreme Light Sensitivity): This is often consensual photophobia—shining light into the unaffected eye causes pain in the affected eye because both pupils constrict simultaneously, pulling on the inflamed iris sphincter.
• Ciliary Flush (Circumcorneal Injection): Unlike conjunctivitis, where blood vessels are engorged at the periphery of the sclera, iritis presents with a violaceous ring of injection concentrated immediately around the limbus (the junction of the cornea and sclera). This represents dilation of the deep episcleral vessels.
• Decreased Visual Acuity: Ranging from mild blurriness to severe impairment, caused by suspended inflammatory debris in the visual axis, corneal edema, or macular involvement.
• Lacrimation: Excess tearing without purulent discharge (which helps differentiate it from bacterial conjunctivitis).

4. Standard Diagnostic Evaluation & Workup

Diagnostic evaluation must be systematic, aiming to grade the severity of the inflammation, rule out posterior segment involvement, and identify any underlying systemic diseases.

Ophthalmic Slit-Lamp Examination (The Gold Standard)

The slit-lamp biomicroscope is the primary diagnostic tool. The ophthalmologist evaluates several key structures:

1. Aqueous Cells and Flare

According to the Standardization of Uveitis Nomenclature (SUN) Working Group, cells and flare are graded quantitatively using a $1 \times 1\text{ mm}$ light beam at maximal intensity:

• Anterior Chamber Cells (Leukocytes):
• Grade 0: $< 1$ cell
• Grade 0.5+: $1\text{ to }5$ cells
• Grade 1+: $6\text{ to }15$ cells
• Grade 2+: $16\text{ to }25$ cells
• Grade 3+: $26\text{ to }50$ cells

• Grade 4+: $> 50$ cells / Hypopyon (a visible layer of white blood cells settling at the bottom of the anterior chamber).

• Anterior Chamber Flare (Protein Leakage):

• Grade 0: None
• Grade 1+: Faint (just detectable)
• Grade 2+: Moderate (iris details clear)
• Grade 3+: Marked (iris details hazy)
• Grade 4+: Intense (coagulated fibrin in aqueous)

2. Keratic Precipitates (KPs)

These are inflammatory cellular deposits on the posterior surface of the corneal endothelium.
* Fine/Non-Granulomatous KPs: Small, white-to-translucent deposits consisting of lymphocytes and neutrophils, typical of acute HLA-B27 uveitis.
* Mutton-Fat/Granulomatous KPs: Large, greasy-looking, yellowish clusters composed of macrophages and epithelioid cells, classic for Sarcoidosis, Tuberculosis, or Syphilis.

   [CORNEA]
      |
 (Posterior Endothelium)
      |
+-----+-----+
|           |

[Fine KPs] [Mutton-Fat KPs]
(Non-Granulomatous) (Granulomatous/Sarcoid)

3. Iris Changes

• Posterior Synechiae: Adhesions between the posterior surface of the iris and the anterior lens capsule. This can result in an irregular, non-reactive pupil (festooned pupil). If 360 degrees of adhesion occur (seclusio pupillae), aqueous flow is blocked, leading to iris bombé and acute secondary angle-closure glaucoma.
• Iris Nodules: Koeppe nodules (located at the pupillary border) and Bussaca nodules (located on the iris stroma), highly indicative of granulomatous uveitis.

Lab Assays & Radiographic Workup

A systemic workup is generally indicated for bilateral, recurrent, chronic, or granulomatous anterior uveitis.

• HLA-B27 Genotyping: To identify spondyloarthropathy associations.
• Syphilis Serology: Treponemal (FTA-ABS, TP-PA) and non-treponemal (RPR, VDRL) assays.
• Serum Angiotensin-Converting Enzyme (ACE) & Lysozyme: Screen for Sarcoidosis.
• Interferon-Gamma Release Assay (IGRA) / Quantiferon-TB Gold: To screen for Tuberculosis.
• Antinuclear Antibodies (ANA): Essential in pediatric patients to evaluate for JIA.
• Imaging:
• Chest X-ray / High-Resolution Chest CT: To evaluate for bilateral hilar adenopathy (Sarcoidosis) or pulmonary lesions (TB).
• Sacroiliac Joint X-ray / MRI: If Ankylosing Spondylitis is suspected based on lower back pain history.

5. Therapeutic Interventions

The primary goals of treatment are to eliminate intraocular inflammation, alleviate ocular pain, prevent the formation of posterior synechiae, and minimize structural complications.

Pharmacotherapy

1. Topical Corticosteroids

Topical corticosteroids are the cornerstone of therapy for non-infectious anterior uveitis.
* First-Line Agent: Prednisolone acetate 1% ophthalmic suspension (e.g., Pred Forte). It has excellent corneal penetration. Other options include Difluprednate 0.05% (Durezol), a highly potent emulsion requiring less frequent dosing.
* Dosing Regimen: In severe acute cases, dosing starts aggressively (e.g., 1 drop every 1 to 2 hours) and is gradually tapered over several weeks to months based on the resolution of anterior chamber cells. Crucial Clinical Note: Steroids must never be stopped abruptly, as this can trigger a severe rebound inflammatory response.
* Monitoring: Patients on long-term topical steroids must be monitored for steroid-induced intraocular pressure (IOP) elevation ("steroid responders") and posterior subcapsular cataract formation.

2. Mydriatic and Cycloplegic Agents

These drops dilate the pupil and paralyze the ciliary muscle.
* Agents: Homatropine hydrobromide 5%, Cyclopentolate 1%, or Atropine sulfate 1%.
* Therapeutic Mechanism:
1. Pain Relief: Relieves the painful spasm of the ciliary muscle and iris sphincter.
2. Synechiae Prevention/Disruption: By keeping the pupil dilated, it moves the iris away from the anterior lens capsule, preventing adhesions. If fresh synechiae are present, aggressive in-office dilation can break them.

3. Systemic Immunomodulatory Therapy (IMT)

For chronic, bilateral, or steroid-dependent cases (especially JIA-associated uveitis or severe sarcoidosis), systemic therapy is indicated:
* Antimetabolites: Methotrexate, Mycophenolate Mofetil.
* Biologics: TNF-$\alpha$ inhibitors like Adalimumab (Humira) or Infliximab (Remicade).

4. Antimicrobials

If an infectious etiology is confirmed:
* Herpetic Uveitis: Topical and systemic antivirals (e.g., Acyclovir, Valacyclovir) are administered alongside corticosteroids to prevent viral replication.
* Syphilitic/Tubercular Uveitis: Targeted systemic antibiotic/antitubercular regimens are required.

Surgical Interventions

Surgery is reserved for managing secondary complications:
* Cataract Extraction: Performed only when intraocular inflammation has been completely controlled (0 cells) for at least three consecutive months.
* Glaucoma Surgery: If medical therapy fails to control secondary inflammatory glaucoma, procedures like Trabeculectomy, Glaucoma Drainage Device (GDD) implantation, or Minimally Invasive Glaucoma Surgery (MIGS) may be required.
* Laser Peripheral Iridotomy (LPI): Performed to relieve pupillary block caused by 360-degree posterior synechiae (seclusio pupillae).

Lifestyle Modifications & Long-Term Prognosis

• Smoking Cessation: Smoking is clinically proven to worsen uveitis outcomes and increase flare-up frequency.
• Blue/UV Protection: Wearing wrap-around polarized sunglasses mitigates severe photophobia during acute flares.
• Prognosis: The prognosis for acute anterior uveitis is generally excellent when diagnosed early and treated appropriately. However, chronic or recurrent disease requires diligent, long-term ophthalmic surveillance to prevent cumulative structural damage to the eye.

6. Frequently Asked Questions (FAQs)

1. What is the difference between anterior uveitis and iritis?

Iritis is the inflammation of the iris (the colored part of the eye) alone. Anterior uveitis is a slightly broader medical term that encompasses both iritis and iridocyclitis (inflammation of both the iris and the adjacent ciliary body). In clinical practice, these two terms are often used interchangeably to describe inflammation localized to the front chamber of the eye.

2. Can anterior uveitis cause permanent blindness?

Yes, if left untreated or inadequately managed, chronic or severe recurrent anterior uveitis can lead to permanent vision loss. Blindness occurs due to secondary complications such as inflammatory glaucoma (damage to the optic nerve), dense cataracts, band keratopathy (calcium deposits on the cornea), or cystoid macular edema (swelling of the central retina). However, with timely diagnosis and appropriate steroid therapy, permanent vision loss is highly preventable.

3. Why does my eye hurt when light is shone into my other, healthy eye?

This phenomenon is known as consensual photophobia and is a classic diagnostic sign of iritis. When light is shone into your healthy eye, both pupils naturally constrict at the same time (the pupillary light reflex). When the pupil of the inflamed eye tries to constrict, it causes the inflamed iris muscle to pull and spasm, triggering deep ocular pain even though no light entered that eye directly.

4. What is the link between anterior uveitis and the HLA-B27 gene?

HLA-B27 is a genetic marker (a human leukocyte antigen) present in about 8% of the general population but found in up to 50% of patients with acute anterior uveitis. People who carry this gene are highly predisposed to developing autoimmune inflammatory conditions, particularly seronegative spondyloarthropathies like ankylosing spondylitis, reactive arthritis, and inflammatory bowel disease, which frequently present with recurrent eye inflammation.

5. How long does a typical flare-up of iritis last?

With prompt and proper treatment using topical corticosteroid and cycloplegic drops, a typical episode of acute anterior uveitis resolves within 4 to 6 weeks. However, some cases can become chronic, lasting for more than 3 months, or may recur periodically over several years, requiring long-term monitoring and maintenance therapy.

6. Can stress trigger an anterior uveitis flare-up?

Yes, clinical evidence and patient reports suggest that psychological and physical stress can act as triggers for recurrent uveitis flare-ups. Stress alters systemic immune function and increases the release of inflammatory cytokines, which can disrupt the blood-aqueous barrier in predisposed individuals and reactivate latent uveal inflammation.

7. How do doctors distinguish iritis from pink eye (conjunctivitis)?

While both conditions cause eye redness, they have distinct clinical differences:
* Iritis presents with a deep, aching pain, extreme light sensitivity (photophobia), a constricted pupil, a ciliary flush (redness concentrated closely around the iris), and watery tearing without pus.
* Conjunctivitis typically causes mild grittiness or burning rather than deep pain, does not cause severe photophobia, presents with normal pupil reactions, diffuse redness across the entire white of the eye, and is accompanied by a sticky, yellow, or green discharge.

8. Why must I taper my steroid eye drops instead of stopping them suddenly?

Corticosteroid eye drops work by suppressing the active immune response inside the eye. If you stop using them suddenly, the immune system can react with a "rebound phenomenon," causing a rapid, severe return of the inflammation that may be more difficult to control than the initial flare-up. Tapering the drops slowly allows the blood-aqueous barrier to stabilize and prevents recurrence.

9. What are "mutton-fat" keratic precipitates?

Keratic precipitates (KPs) are clumps of inflammatory cells that stick to the inner back surface of the cornea. "Mutton-fat" KPs are large, yellowish, greasy-looking deposits composed of macrophages and epithelioid cells. Their presence indicates a granulomatous inflammatory process, which helps narrow down the cause to conditions like Sarcoidosis, Tuberculosis, or Syphilis.

10. Is anterior uveitis hereditary?

Anterior uveitis itself is not directly inherited, but the genetic predisposition to developing it can be passed down. Specifically, the HLA-B27 gene is hereditary. If you carry this gene, you have a significantly higher risk of developing uveitis and associated autoimmune joint diseases, though not everyone with the gene will develop these conditions.

Related Clinical Integration

In a modern clinical setting, the management of Anterior Uveitis (Iritis) requires a multidisciplinary approach that integrates precise diagnostic evaluation with targeted therapeutic interventions and systemic disease screening. The initial diagnosis is facilitated by the use of a Slit lamp biomicroscope / مجهر حيوي بضوء شقي (أجهزة دعم وتكبير الجراحة) to identify inflammatory cells in the anterior chamber, which is typically followed by the administration of Cycloplegic eye drops (e.g., cyclopentolate) / قطرات عينية مشلة للعضلة الهدبية (مثل: سيكلوبنتولات) Standard to prevent synechiae and manage pain, or Depo-Medrol / ديبو-ميدرول 80 mg for potent anti-inflammatory control in severe cases. Given that anterior uveitis is frequently a sentinel manifestation of underlying systemic autoimmune conditions, clinicians must maintain a high index of suspicion for rheumatological pathologies such as Ankylosing Spondylitis and Juvenile Idiopathic Arthritis (JIA). Consequently, practitioners should utilize our comprehensive educational resources, including Operative Management of Ankylosing Spondylitis: A Comprehensive Surgical Guide, Orthopedic & Rheumatology Board Review: JIA, Bone Tumors, Syringomyelia Cases | Part 8, Master ABOS Orthopedic Board Review: Dysplasias, Osteomalacia, Infections, JIA | Part 7, Orthopedic Board Review: Musculoskeletal Tumors, Ankylosing Spondylitis, Synovial Chondromatosis | Part 15, and